Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherRevenue - OtherShares Issued
Ratios

Perspective Therapeutics (CATX) Shares Issued (2016 - 2025)

Perspective Therapeutics (CATX) has disclosed Shares Issued for 15 consecutive years, with -$371000.0 as the latest value for Q4 2025.

  • Quarterly Shares Issued fell 132.89% to -$371000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Sep 2025, up 185.52% year-over-year, with the annual reading at $1.3 million for FY2024, 244.23% up from the prior year.
  • Shares Issued hit -$371000.0 in Q4 2025 for Perspective Therapeutics, down from $371000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $7.8 million in Q1 2021 to a low of -$371000.0 in Q4 2025.
  • Historically, Shares Issued has averaged $861909.1 across 5 years, with a median of $28000.0 in 2022.
  • Biggest YoY gain for Shares Issued was 18450.0% in 2025; the steepest drop was 132.89% in 2025.
  • Year by year, Shares Issued stood at -$28000.0 in 2021, then surged by 200.0% to $28000.0 in 2022, then soared by 1328.57% to $400000.0 in 2023, then surged by 182.0% to $1.1 million in 2024, then crashed by 132.89% to -$371000.0 in 2025.
  • Business Quant data shows Shares Issued for CATX at -$371000.0 in Q4 2025, $371000.0 in Q3 2025, and $1.1 million in Q4 2024.